Navigation Links
New research effort into causes of chronic fatigue syndrome
Date:9/27/2011

September 27, 2011 --The Chronic Fatigue Initiative (CFI) a new privately funded research directive focused on chronic fatigue syndrome announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.

Chronic fatigue syndrome is a condition believed to affect about 1million Americans. It is characterized by symptoms similar to those of common viral infections and can include muscle aches, headache and extreme fatigue. Its cause is unknown, and currently there is no cure.

Established by a donation of more than $10 million from the Hutchins Family Foundation, the Chronic Fatigue Initiative will bring together medical experts from the world's leading research institutions, including Columbia, Harvard, Stanford and Duke Universities. The Initiative's initial phase of funding includes support for pathogenesis research at the Center for Infection and Immunity, and for NewYork-Presbyterian Hospital/Columbia University Medical Center, where it will establish the Hutchins Family Fellowship in Infectious Disease under the direction of Dr. Scott Hammer, professor of epidemiology and chief of the Division of Infectious Diseases at NewYork-Presbyterian/Columbia.

"Dr. Hornig was the prime mover in designing the research plan and will be shepherding the CFI's research at the Center for Infection and Immunity," said Dr. Lipkin, the director of CII.

Dr. Hornig, an associate professor of epidemiology at the Mailman School of Public Health and director of Translational Research at CII, will direct research on biomarkers and pathogen discovery for the Chronic Fatigue Initiative. The research will focus on characterizing the causes of this enigmatic disorder.

Scientists will examine samples from 200 patients and controls using state-of-the-art molecular techniques pioneered at CII. Patients will be recruited across the country from five clinical sites that specialize in chronic fatigue syndrome.

During the first part of the project, they will screen for already known pathogens thought to be associated with the disease. Then they will use unbiased genetic sequencing to help them identify any novel pathogens. CII scientists will also look at patients' host response profiles the immune molecule and antibody signatures in their peripheral blood samples. This will enable researchers to get a comprehensive picture of what is happening in individual patients in relation to pathogens to which they may have been exposed and could lead to the identification of biomarkers for CFS.

Drs. Lipkin and Hornig will also collaborate with Dr. Scott M. Hammer and the inaugural Hutchins Family Fellow for Infectious Disease at NewYork-Presbyterian/Columbia Dr. Claire Gordon.

"This is a truly exciting opportunity to understand the causes of this often neglected disorder," said Dr. Hornig. "We hope our findings will lead to better diagnoses and the development of an effective treatment."


'/>"/>

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: